Work

Genomic predictors of benefit of docetaxel (D) and next-generation hormonal therapy (NHT) in metastatic castration resistant prostate cancer (mCRPC).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.5018

Authors: Anis Hamid, Himisha Beltran, Atish Dipankar Choudhury, Christopher Sweeney

Institutions: Dana-Farber Cancer Institute, Weill Cornell Medicine

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2946849738

Cites:

Cited by: 3

Related to: 10